• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含双四氢呋喃的拟对称二肽等排体的强效杂交型HIV-1蛋白酶抑制剂的结构分析

Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere.

作者信息

Rusere Linah N, Lockbaum Gordon J, Henes Mina, Lee Sook-Kyung, Spielvogel Ean, Rao Desaboini Nageswara, Kosovrasti Klajdi, Nalivaika Ellen A, Swanstrom Ronald, Kurt Yilmaz Nese, Schiffer Celia A, Ali Akbar

机构信息

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.

Department of Biochemistry and Biophysics, and the UNC Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

出版信息

J Med Chem. 2020 Aug 13;63(15):8296-8313. doi: 10.1021/acs.jmedchem.0c00529. Epub 2020 Aug 3.

DOI:10.1021/acs.jmedchem.0c00529
PMID:32672965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7971191/
Abstract

The design, synthesis, and X-ray structural analysis of hybrid HIV-1 protease inhibitors (PIs) containing bis-tetrahydrofuran (bis-THF) in a pseudo-C-symmetric dipeptide isostere are described. A series of PIs were synthesized by incorporating bis-THF of darunavir on either side of the Phe-Phe isostere of lopinavir in combination with hydrophobic amino acids on the opposite P2/P2' position. Structure-activity relationship studies indicated that the bis-THF moiety can be attached at either the P2 or P2' position without significantly affecting potency. However, the group on the opposite P2/P2' position had a dramatic effect on potency depending on the size and shape of the side chain. Cocrystal structures of inhibitors with wild-type HIV-1 protease revealed that the bis-THF moiety retained similar interactions as observed in the darunavir-protease complex regardless of the position on the Phe-Phe isostere. Analyses of cocrystal structures and molecular dynamics simulations provide insights into optimizing HIV-1 PIs containing bis-THF in non-sulfonamide dipeptide isosteres.

摘要

本文描述了在拟C对称二肽等排体中含有双四氢呋喃(bis-THF)的混合型HIV-1蛋白酶抑制剂(PI)的设计、合成及X射线结构分析。通过将达芦那韦的双四氢呋喃引入洛匹那韦的苯丙氨酸-苯丙氨酸等排体两侧,并在相对的P2/P2'位置结合疏水氨基酸,合成了一系列PI。构效关系研究表明,双四氢呋喃部分可连接在P2或P2'位置,而不会显著影响活性。然而,相对的P2/P2'位置上的基团对活性有显著影响,这取决于侧链的大小和形状。抑制剂与野生型HIV-1蛋白酶的共晶体结构表明,无论在苯丙氨酸-苯丙氨酸等排体上的位置如何,双四氢呋喃部分都保留了与达芦那韦-蛋白酶复合物中观察到的类似相互作用。共晶体结构分析和分子动力学模拟为优化非磺酰胺二肽等排体中含有双四氢呋喃的HIV-1 PI提供了见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/81ed6bf388e5/nihms-1641040-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/850b02c40665/nihms-1641040-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/42e6d42211c1/nihms-1641040-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/18b7e32e3f7d/nihms-1641040-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/c2ec8f326786/nihms-1641040-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/1c555a80faee/nihms-1641040-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/1bdd085a7c65/nihms-1641040-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/dfd5817918a0/nihms-1641040-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/daf44c4c2944/nihms-1641040-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/95c4ff677cde/nihms-1641040-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/14b55b83f008/nihms-1641040-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/81ed6bf388e5/nihms-1641040-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/850b02c40665/nihms-1641040-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/42e6d42211c1/nihms-1641040-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/18b7e32e3f7d/nihms-1641040-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/c2ec8f326786/nihms-1641040-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/1c555a80faee/nihms-1641040-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/1bdd085a7c65/nihms-1641040-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/dfd5817918a0/nihms-1641040-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/daf44c4c2944/nihms-1641040-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/95c4ff677cde/nihms-1641040-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/14b55b83f008/nihms-1641040-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fbf/7971191/81ed6bf388e5/nihms-1641040-f0012.jpg

相似文献

1
Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere.含双四氢呋喃的拟对称二肽等排体的强效杂交型HIV-1蛋白酶抑制剂的结构分析
J Med Chem. 2020 Aug 13;63(15):8296-8313. doi: 10.1021/acs.jmedchem.0c00529. Epub 2020 Aug 3.
2
Design and synthesis of HIV-1 protease inhibitors incorporating oxazolidinones as P2/P2' ligands in pseudosymmetric dipeptide isosteres.在假对称二肽类似物中,将恶唑烷酮作为P2/P2'配体的HIV-1蛋白酶抑制剂的设计与合成。
J Med Chem. 2007 Sep 6;50(18):4316-28. doi: 10.1021/jm070284z. Epub 2007 Aug 16.
3
GRL-09510, a Unique P2-Crown-Tetrahydrofuranylurethane -Containing HIV-1 Protease Inhibitor, Maintains Its Favorable Antiviral Activity against Highly-Drug-Resistant HIV-1 Variants in vitro.GRL-09510,一种含有独特 P2-冠醚四氢呋喃基脲的 HIV-1 蛋白酶抑制剂,在体外对高度耐药的 HIV-1 变异体保持其有利的抗病毒活性。
Sci Rep. 2017 Sep 25;7(1):12235. doi: 10.1038/s41598-017-12052-9.
4
Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance.靶向蛋白质主链的HIV蛋白酶抑制剂设计:一种对抗耐药性的有效策略。
Acc Chem Res. 2008 Jan;41(1):78-86. doi: 10.1021/ar7001232. Epub 2007 Aug 28.
5
GRL-0519, a novel oxatricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor (PI), potently suppresses replication of a wide spectrum of multi-PI-resistant HIV-1 variants in vitro.GRL-0519,一种新型含噁三嗪环配体的非肽类 HIV-1 蛋白酶抑制剂(PI),能够在体外强有力地抑制多种对 PI 耐药的 HIV-1 变异体的复制。
Antimicrob Agents Chemother. 2013 May;57(5):2036-46. doi: 10.1128/AAC.02189-12. Epub 2013 Feb 12.
6
Novel Protease Inhibitors Containing C-5-Modified -Tetrahydrofuranylurethane and Aminobenzothiazole as P2 and P2' Ligands That Exert Potent Antiviral Activity against Highly Multidrug-Resistant HIV-1 with a High Genetic Barrier against the Emergence of Drug Resistance.含 C-5 修饰的四氢呋喃脲基和氨基苯并噻唑的新型蛋白酶抑制剂作为 P2 和 P2'配体,对具有高度遗传耐药屏障的高度多重耐药 HIV-1 发挥强大的抗病毒活性,不易产生耐药性。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00372-19. Print 2019 Aug.
7
Novel Central Nervous System (CNS)-Targeting Protease Inhibitors for Drug-Resistant HIV Infection and HIV-Associated CNS Complications.新型中枢神经系统(CNS)靶向蛋白酶抑制剂治疗耐药性 HIV 感染和 HIV 相关 CNS 并发症。
Antimicrob Agents Chemother. 2019 Jun 24;63(7). doi: 10.1128/AAC.00466-19. Print 2019 Jul.
8
Substituted Bis-THF Protease Inhibitors with Improved Potency against Highly Resistant Mature HIV-1 Protease PR20.对高度耐药的成熟HIV-1蛋白酶PR20具有更高活性的取代双四氢呋喃蛋白酶抑制剂。
J Med Chem. 2015 Jun 25;58(12):5088-95. doi: 10.1021/acs.jmedchem.5b00474. Epub 2015 Jun 4.
9
P2' benzene carboxylic acid moiety is associated with decrease in cellular uptake: evaluation of novel nonpeptidic HIV-1 protease inhibitors containing P2 bis-tetrahydrofuran moiety.P2' 苯羧酸部分与细胞摄取减少相关:含 P2 双四氢呋喃部分的新型非肽类 HIV-1 蛋白酶抑制剂的评估。
Antimicrob Agents Chemother. 2013 Oct;57(10):4920-7. doi: 10.1128/AAC.00868-13. Epub 2013 Jul 22.
10
A conserved hydrogen-bonding network of P2 bis-tetrahydrofuran-containing HIV-1 protease inhibitors (PIs) with a protease active-site amino acid backbone aids in their activity against PI-resistant HIV.含P2双四氢呋喃的HIV-1蛋白酶抑制剂(PIs)与蛋白酶活性位点氨基酸主链形成的保守氢键网络有助于其对PI耐药型HIV的活性。
Antimicrob Agents Chemother. 2014 Jul;58(7):3679-88. doi: 10.1128/AAC.00107-14. Epub 2014 Apr 21.

引用本文的文献

1
HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residues.具有 P1 膦酸酯修饰的 HIV-1 蛋白酶抑制剂通过与瓣状残基的增强相互作用保持对耐药变异体的效力。
Eur J Med Chem. 2023 Sep 5;257:115501. doi: 10.1016/j.ejmech.2023.115501. Epub 2023 May 18.
2
Beyond darunavir: recent development of next generation HIV-1 protease inhibitors to combat drug resistance.超越达芦那韦:新一代 HIV-1 蛋白酶抑制剂抵抗耐药性的最新进展。
Chem Commun (Camb). 2022 Oct 20;58(84):11762-11782. doi: 10.1039/d2cc04541a.
3
Viral proteases: Structure, mechanism and inhibition.

本文引用的文献

1
Proton transfer and drug binding details revealed in neutron diffraction studies of wild-type and drug resistant HIV-1 protease.野生型和耐药型HIV-1蛋白酶的中子衍射研究揭示的质子转移和药物结合细节。
Methods Enzymol. 2020;634:257-279. doi: 10.1016/bs.mie.2019.12.002. Epub 2020 Jan 10.
2
HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands To Optimize Hydrogen Bonding in the Substrate Envelope.包含立体定义的 P2' 配体以优化底物信封中氢键的 HIV-1 蛋白酶抑制剂。
J Med Chem. 2019 Sep 12;62(17):8062-8079. doi: 10.1021/acs.jmedchem.9b00838. Epub 2019 Aug 21.
3
Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance.
病毒蛋白酶:结构、机制与抑制。
Enzymes. 2021;50:301-333. doi: 10.1016/bs.enz.2021.09.004. Epub 2021 Nov 17.
皮摩尔至微摩尔:阐明 HIV-1 蛋白酶远端突变在赋予耐药性方面的作用。
ACS Chem Biol. 2019 Nov 15;14(11):2441-2452. doi: 10.1021/acschembio.9b00370. Epub 2019 Aug 13.
4
Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease.达芦那韦类似物针对HIV-1蛋白酶原发性突变的结构适应性
ACS Infect Dis. 2019 Feb 8;5(2):316-325. doi: 10.1021/acsinfecdis.8b00336. Epub 2018 Dec 31.
5
Sub-picomolar Inhibition of HIV-1 Protease with a Boronic Acid.硼酸盐对 HIV-1 蛋白酶的亚皮摩尔抑制作用。
J Am Chem Soc. 2018 Oct 31;140(43):14015-14018. doi: 10.1021/jacs.8b07366. Epub 2018 Oct 22.
6
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.抗逆转录病毒药物治疗和预防成人 HIV 感染:美国国际抗病毒学会 2018 年推荐意见。
JAMA. 2018 Jul 24;320(4):379-396. doi: 10.1001/jama.2018.8431.
7
Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors Containing Tricyclic Fused Ring Systems as Novel P2 Ligands: Structure-Activity Studies, Biological and X-ray Structural Analysis.含三环稠合环系作为新型 P2 配体的高效抗 HIV-1 蛋白酶抑制剂的设计与合成:构效关系研究、生物学及 X 射线结构分析。
J Med Chem. 2018 May 24;61(10):4561-4577. doi: 10.1021/acs.jmedchem.8b00298. Epub 2018 May 15.
8
Hydration Structure and Dynamics of Inhibitor-Bound HIV-1 Protease.抑制剂结合的 HIV-1 蛋白酶的水合结构和动力学。
J Chem Theory Comput. 2018 May 8;14(5):2784-2796. doi: 10.1021/acs.jctc.8b00097. Epub 2018 Apr 18.
9
Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease Inhibitors.导致高效HIV-1蛋白酶抑制剂的哌嗪磺酰胺核心结构的设计与合成
ACS Med Chem Lett. 2017 Nov 13;8(12):1292-1297. doi: 10.1021/acsmedchemlett.7b00386. eCollection 2017 Dec 14.
10
A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency.一种新型中枢神经系统穿透性蛋白酶抑制剂以空前的 aM 至 pM 效力克服人类免疫缺陷病毒 1 耐药性。
Elife. 2017 Oct 17;6:e28020. doi: 10.7554/eLife.28020.